INTRODUCTION
The kidney is essential for metabolic waste excretion, the homeostatic balance of tissue fluids (water, salt, and pH), blood pressure and cell composition, and bone development and metabolism. Filtration is performed within the renal corpuscles (RCs) by a highly structured cellular device. This comprises a convoluted fenestrated glomerular endothelium supported by mesangial myofibroblasts that releases a plasma filtrate that enters the nephron between slit diaphragms generated by the foot processes of tightly adherent podocytes. Establishment of the glomerular filter is initiated by a stereotypic recruitment of pioneering endothelial cells to the developing podocytes followed secondarily by interstitial cells into the glomerular cleft of Comma and S-Shaped bodies (CSBs and SSBs) and sequential capillary formation (Figures 1A and 1B) . Podocytes support development and maintenance of the glomerular vasculature via VEGFA (Eremina et al., 2003; Sison et al., 2010) , whereas endothelial-derived PDGF signals promote mesangial development (Bjarnegå rd et al., 2004; Lindahl et al., 1998) before RC maturation ( Figure 1C ) (Levé en et al., 1994; Soriano, 1994) . Single gene mutations resulting in end-stage renal disease cluster in genes showing podocyte-enriched expression, highlighting the central role of podocytes in normal kidney function (Brenner et al., 1996; Zhong et al., 2017) . Advances in pluripotent stem cell-derived kidney organoid systems support parallel efforts to mechanistically dissect human kidney development to gain new insights into developmental programs relevant to treating or modeling disease states or generating functional systems (Takasato et al., 2016; Morizane et al., 2015; Wilson and Humphreys, 2019; Taguchi and Nishinakamura, 2015; Combes et al., 2019) . A human-focused understanding of kidney development will complement other mammalian model systems to maximize effective application, predict new disease relationships, and identify novel developmental mechanisms (Combes et al., 2019; Lindströ m et al., 2018a Lindströ m et al., , 2018b Lindströ m et al., , 2018c Menon et al., 2018; Wu et al., 2018) .
RESULTS

Single-Nucleus Interrogation of Human Fetal Kidney
To generate insights into RC formation, we applied snDrop-seq to transcriptionally profile nuclei isolated from human fetal kidneys (Figure 2A ). Our group, and others, have captured single-nuclear transcriptomes from other challenging tissues including postmortem adult brain (Lake et al., , 2018 resolving distinct cell types Wu et al., 2019) . The benefits of the nuclear approach are that cryopreserved tissue with potentially clinical value are compatible and epithelialized cells including those of sieved mature RCs are more accessible than by enzymatic cell dissociation methods required for whole cell. Podocytes are consistently under-represented (or missing) from prominent large kidney single cell RNA sequencing (RNA-seq) datasets (Adam et al., 2017; Park et al., 2018) . Furthermore, our previous studies were unable to sufficiently access epithelialized cell types beyond SSB using an enzymatic cortical digestion method (Lindströ m et al., 2018a (Lindströ m et al., , 2018b (Lindströ m et al., , 2018d . To this end, we processed nephrogenic cortex and RCs from 13-to 16.5-week human fetal kidney samples that incorporated all stages of RC development to active filtering nephrons (Figures 2A and S1 , Table S1 ). Nuclear RNA preferentially detects genes with high intron count compared with whole-cell RNA, leading to a systemic biased sensitivity toward genes that may escape detection in conventional single-cell approaches. Variable numbers of nuclei were obtained from each sample; whether the variation in number of nuclei reflects biological variability among the samples or technical variability in the procedures is not clear. Altogether, we generated data on 7,018 single nuclei from these combined samples sequenced to an average depth of 10,298 useful reads per nucleus (Table S1 ). This permitted detection of a median of 879 unique transcripts and 707 genes per nucleus, with genomic mapping rates showing the expected higher proportion of reads corresponding to intronic sequences (Table S1) , as previously observed.
To resolve the cell type composition, we analyzed transcriptional heterogeneity by grouping cells by genegene covariance (see Transparent Methods). This approach identified twelve nephrogenic, five interstitial, one immune, and one endothelial cluster (Figure 2A and Tables S2 and S3 ). Clusters showed expression profiles and subgroup aggregations visualized with Uniform Manifold Approximation and Projection (UMAP) (Becht et al., 2018) , independent of technical batch effects ( Figures 2B, 2C , and S1). Cluster identification was supported by GO-Term analysis, immunohistological (protein-targeted) and in situ hybridization (mRNA-targeted) analysis with select known markers of mammalian kidney development, including LTBP1 (Schwab et al., 2006; Fetting et al., 2014) , CDH4 (Dahl et al., 2002; Rosenberg et al., 1997) , COL4A1 Chew and Lennon, 2018) , disease-related genes ESRRG (Berry et al., 2011; Harewood et al., 2010) , PKHD1 (Igarashi and Somlo, 2002; Wilson, 2004) , and novel marker PAMR1 ( Figure S2 , Tables  S4 and S5 ). To visualize and infer relationships between clusters we employed similarity weighted nonnegative embedding (SWNE) analysis ( Figure 2D ) (Wu et al., 2018b) . Nephron progenitor cells (NPCs) and mitotic NPCs (cNPC) clusters were related to two differentiated NPC (dNPC) clusters enriched from cortex ( Figure S1 ). Differentiated tubular clusters comprised medial/distal and proximal tubular identities ( Figure 2D ). DNPCs transitioned to parietal epithelium (PE), and podocyte clusters enriched in RC samples (Figures 2B and S1) . Interstitial clusters were composed of interstitial progenitor cells (IPCs), mitotic interstitium (cINT), and three populations containing two mesangial clusters enriched in RC samples (INT1-3) (Figures 2B and S1).
Molecular Dissection of Podocyte Development
Given the nucleating role of the podocyte in the development of a glomerular filter we hypothesized that transiently expressed genes during podocyte development could be important coordinating glomerular and mesangial cell programs. An unsupervised pseudotemporal analysis in Monocle was used to identify intermediates in the podocyte developmental pathway ( Figures 2C-2E , S3, and S4) (Qiu et al., 2017) . Monocle analysis predicted that NPCs transitioned to dNPCs that expressed PAX8, JAG1, and LHX1 (Park et al., 2007; Leimeister et al., 2003; Plachov et al., 1990) (Figures 2D-2G, Tables S6 and S7 ). Lhx1 plays a key early role in mouse podocyte programs and mutations in LHX1 associated with congenital anomalies of the kidney and urinary tract (CAKUT) syndrome (Kobayashi et al., 2005; Boualia et al., 2013; Lindströ m et al., 2018d) . Additionally, JAG1 and PAX8 are two markers of early nephron that are involved in kidney development and disease (Boualia et al., 2013; Narlis et al., 2007; Plachov et al., 1990; Lindströ m et al., 2018c; Liu et al., 2013; Chen and Al-Awqati, 2005; Piscione et al., 2004) . DNPCs bifurcated between Figure 1 . Continued podocytes. Podocyte-derived VEGFA signaling to glomerular endothelial cells and PDGF secreted by endothelial cells acting on adjacent mesangial precursors are critical for the development, maintenance, and function of glomerular filtration. (B) Immunostaining showing incremental stages of glomerular capillary tuft development starting with invasion of PECAM1+ endothelial cells (yellow) followed by PDGFRB + interstitial cells (cyan) into the glomerular cleft (left to right panels). (C) Immunohistochemical staining of distinct stages of RC development labeling WT1+ PE, WT1+ podocytes colocalized with VEGFA (cyan arrowhead), and PECAM1+ endothelium colocalized with PDGF (red arrowhead). (Scale bars, 25 mm). Prox, Proximal Nephron; Pod, Podocytes; PE, Parietal Epithelium; End, Endothelium; CSB, Comma-Shaped Body; CLN, Capillary Loop Nephron; RC, Renal Corpuscle. (Table S1) Table S6 ). Glomerulusrelated GO Terms were associated with the proximal branch, whereas cytoskeletal processes were associated with the medial/distal branch (Tables S7-S11). Monocle analysis of proximal transcriptomes bifurcated podocyte and PE trajectories ( Figures 2F, 2G , and S2E-S2E'). Global pseudotemporal analysis of this dataset identified eight temporally distinct gene sets (GS1-GS8) with distinct ontologies (Figures 3A and 3B, and Table S12 ). At one end, NPCs (GS1) expressed ROBO2 and ECEL (Lindströ m et al., 2018b), whereas at the other end, mature podocytes (GS8) expressed FOXC1, SYNPO, NPHS2 (Table S12) , key genes in mouse and human podocyte function (Lindströ m et al., 2018a (Lindströ m et al., , 2018b Motojima et al., 2017; Roselli et al., 2004; Yanagida-Asanuma et al., 2007; Mundel et al., 1997; Komaki et al., 2013; Kume et al., 2000; Franceschini et al., 2006; Sharif and Barua, 2018) . GS6-GS8 gene-associated phenotypes included defects in ureteric bud, renal system, and podocyte foot processes accompanied with GO Terms for regulation of development, cell adhesion, and cell movement ( Figure 3B and Table S12 ).
Examining these data for podocyte-derived, stage-specific developmental signals as potential organizers of the glomerular filter identified three expressed factors predicted to display partial temporal overlap: BMP4 (GS6; a member of the BMP subfamily of TGFb signals) (Padgett et al., 1993) , FBLN2 (GS7; a calcium-binding extracellular matrix protein of the fibulin family) (Zhang et al., 1994) , and NTN4 (GS8; a Netrin family member) ( Figure 3C ) (Yin et al., 2000) . In situ hybridization demonstrated each exhibited expression in podocytes (but also other cell types) surrounding the glomerular cleft in conjunction with angioblast recruitment, although their spatiotemporal profiles differed ( Figure 4A ). In particular, FBLN2 was detected at high levels in the earliest podocyte precursors, continued throughout RC development, but terminated in the functional RC ( Figure 4A ). FBLN2 was detected within the glomerular cleft and angioblasts produced PERLECAN/HSPG2, a potential interaction partner for FBLN2 (Brown et al., 1997) (Figures 4B and 4C ). UNC5B, a surface receptor for NTN4 known to be involved in diabetic nephropathy (Lu et al., 2004; Hoang et al., 2009; Lejmi et al., 2014; Ranganathan et al., 2015; Wang et al., 2008) , was also detected on the angioblast ( Figures 4D and 4E ), continuing into periglomerular endothelial cells of mature RCs, and on parietal epithelial cells that encapsulated the RC ( Figures 4D and 4F ). Analysis of phospho-SMAD and ERK staining, respectively, suggests evidence including but not limited to potential activation of BMP and FGF signaling within the vascular/mesangial population invading the glomerular cleft ( Figures 4G and 4H ). These data support potential roles for FBLN2, NTN4, and BMP4 in RC assembly from the initial stages of endothelial and interstitial recruitment ( Figure 4I ). Figure 1A . See also Figure S5 . Raatikainen-Ahokas et al., 2000; Ueda et al., 2008; Wang et al., 2008) , and non-glomerular associated Fbln2 expression has been reported in the mouse kidney (Pan et al., 1993) ; however, no specific role has been attached to any of these factors in coordinating glomerular endothelial or mesangial programs in the human kidney. To explore the function of these factors on human vascular and mesangial cell development, biologically relevant primary endothelial and interstitial cell types were isolated from the human fetal kidney by enzymatic dissociation of the cortical region and antibody specific enrichment (anti-VECAD1, endothelial; anti-PDGFRB, interstitial) ( Figure 5A ) and tested for high-affinity responses to nanomolar concentrations of specific factors informed by the previous literature. As expected from published studies (Barkefors et al., 2008) , VEGFA promoted endothelial cell migration through a cell permeable membrane, reflecting VEGFA's known actions in facilitating early assembly of the glomerular vasculature ( Figure 1 ), increased angiogenic tubule formation in Matrigel ( Figures 5B and 5C ), and enhanced endothelial cell proliferation ( Figure S5B ). Interestingly, FBLN2 and NTN4 but not BMP4 also increased endothelial cell migration and angiogenic tube formation but did not alter proliferation suggesting a partial overlap with VEGFAstimulated activities ( Figures 5B-5E , S5A, and S5B). NTN4 has been shown to elicit context-dependent angiogenic or anti-angiogenic responses consistent with observations here (Lambert et al., 2012; Nacht et al., 2009; Hoang et al., 2009 ). FBLN2 has been linked to cell adhesion (Pfaff et al., 1995) , and the transient accumulation in the matrix surrounding migrating endothelial cells in the glomerular cleft is consistent with matrix interactions promoting adhesion and cell spreading ( Figures 4B, 4D , and S5C). To examine FBLN2 action further, a scratch assay was performed on a confluent population of endothelial cells to determine if FBLN2 influences cell spreading at the leading edge, a sensitive and quantitative assay of general cell motility and cytoskeletal spreading in a homogeneous environment that was previously described . A marked increase in lamellar extensions was observed in the presence of FBLN2 and this response was abrogated by co-incubation with Endorepellin, an inhibitory subunit of HSPG2 that is thought to inhibit FBLN2-HSPG2 interactions and is generally anti-angiogenic (Poluzzi et al., 2016; Mongiat et al., 2003; Brown et al., 1997; Douglass et al., 2015) ( Figures 5F and 5G ). Additionally, endothelial cells preferentially adhered to an FBLN2-coated surface, an interaction that was strongly inhibited on addition of Endorepellin ( Figures 5H and 5I ). Together these support a role for podocyte-expressed FBLN2 acting at least in part through endothelial-produced HSPG2 in promoting outgrowth, migration, and adhesion of endothelial cells in glomerular morphogenesis. Interestingly, mouse Fbln2 does not show similar dynamic podocyte restricted activity in RC development and is instead restricted to the apical domain of tubular epithelia ( Figure S5D ). A closely related gene Fbln1 is expressed in the glomerular cleft in mouse but is widely detected, whereas FBLN1 is nearly absent in human kidney tissues suggesting a marked species difference in the regulation of both genes with respect to podocyte development ( Figure S5D ). Although VEGFA, FBLN2, and NTN4 may all act together at early stages of glomerular morphogenesis, only VEGFA and NTN4 are likely to play a continuing role in the maintenance of the glomerular network.
Endothelial and Interstitial Cell Responses to Podocyte-Derived Expressed Factors
Podocyte-directed actions on the interstitial to mesangial cell transition are not well understood. Genetic studies in the mouse have shown endothelial cell-derived PDGFB acts through mesangial cell PDGFRB to promote mesangial cell-dependent formation of the glomerulus (Bjarnegå rd et al., 2004) . PDGF pathway action plays a broader role in regulating pericytes, a myofibroblast-like cell type interacting with nonglomerular vasculature, which shares a common origin from interstitial progenitor cells (Kobayashi et al., 2014) . To initially determine if PDGFRB + cortical interstitial cells show expected responses in vitro, we examined the effects of PDGFB. PDGFB addition enhanced interstitial cell migration across a cell permeable membrane ( Figures 5B and 5C ), and the proliferative stimulus invoked by PDGFB was inhibited by DMPQ (Lo et al., 2017) , a specific PDGFRB inhibitor ( Figures S5A and S5B) . Thus, the in vitro system replicated PDGF/PDGFRB interactions. Interestingly, interstitial cells were also stimulated to migrate by FBLN2 similarly to endothelial cells by a yet unclear mechanism ( Figure 5C ). Interstitial trajectory analysis showed that interstitial progenitor cells generate different interstitial cell types (INT-1/INT-2/INT-3). In conjunction with the developmental progression, differential gene expression analysis predicted an upregulation of the BMP receptor BMPR1B and the transcriptional regulatory factor GATA3, involved in mesangial differentiation (Labastie et al., 1995) in INT-1/INT-2 cells ( Figure 4H and Table S13 ), and an upregulation of BMP signaling inhibitors in INT-3 cells, a yet uncharacterized interstitial cell type (Tables S14 and S15). Both gain and loss of function of Bmp4 in mouse podocytes result in glomerular capillary defects suggesting that precise regulation of BMP signaling is critical in RC programs (Ueda et al., 2008) .
Consistent with a role for BMP signaling in human glomerular development, cells in the glomerular cleft exhibited phospho-SMAD1/5 activity ( Figures 5J and S5F) . Linked nuclear GATA3 raised the possibility that GATA3 may be a target of BMP signaling. In support of this conjecture, exogenous BMP4 induced expression of ID1, an established BMP target (Hollnagel et al., 1999; Ying et al., 2003) , in cultured interstitial cells, and elevated GATA3 levels (Figures 5K, 5L , and S5E). To examine a possible BMP4 GATA3 link, LDN-193189 was added to inhibit BMP type 1 receptor/phospho-SMAD activity in the presence of BMP4 (Brown et al., 2015; Cuny et al., 2008; Yu et al., 2008) . As expected, LDN-193189 inhibited expression of the BMPtarget ID1 ( Figure S5E ). In contrast, qPCR measurement indicated that GATA3 expression was unaltered suggesting that BMP4 elevation of GATA3 is independent of pSMAD1/5 activity ( Figure S5E ). BMPs have also been reported to act through Smad-independent ERK, p38, JNK, and SAPK MAPK pathways (Brown et al., 2015; Oxburgh et al., 2011; Leung-Hagesteijn et al., 2005; Herpin and Cunningham, 2007; Otani et al., 2007) . To address this possibility, the UO126 MEK inhibitor was added to block ERK activity in the presence of BMP4. As expected, UO126 did not perturb BMP4-induced ID1 levels, but GATA3 levels were reduced ( Figure S5E ). However, UO126 alone was sufficient to increase GATA3 to a similar level as BMP4 treatment suggesting that multiple context-dependent signaling inputs may be involved in GATA3 regulation. BMPs are known to induce GATA3 (Peng et al., 2015; Lichtner et al., 2013) and act synergistically with p38 and ERK in some contexts (Brown et al., 2015; Xu et al., 2008; Shim et al., 2009 ). There are likely other sources of BMP4 (Raatikainen-Ahokas et al., 2000) and other signals that regulate GATA3 in the mesangium (Moriguchi et al., 2016; Van Esch et al., 2000) . BMP7 is involved in kidney development and disease (Dudley et al., 1999; Fetting et al., 2014; Godin et al., 1998; Oxburgh et al., 2005) (Figures 4G, 4H , S5F, and S5G), is expressed in later podocyte development (GS7) ( Figure 3B ), and along with BMP4 can induce pERK1/2 and p38 in mouse mesangial cells (Otani et al., 2007) suggesting mesangial BMP responsiveness is likely conserved in mammals.
DISCUSSION
The kidney's filter is a key target for re-building kidney function. The findings here inform on cell interactions that may facilitate this goal (Van Den Berg et al., 2018; Morizane et al., 2017) . The single-nuclear transcriptional profiling reported here complements approaches from our group and others (Adam et al., 2017; Combes et al., 2019; Karaiskos et al., 2018; Lindströ m et al., 2018a Lindströ m et al., , 2018b Lindströ m et al., , 2018c Menon et al., 2018; O'brien et al., 2018; Rutledge et al., 2017; Wilson and Humphreys, 2019; Wu et al., 2018 Wu et al., , 2019 to identify previously unappreciated factors mediating formation of the renal filter. FBLN2, NTN4, and BMP4 are expressed by developing podocytes concomitant with angioblast and interstitial cell recruitment expressing cognate interacting factors indicating related and potentially concerted actions in the establishment of the glomerular filter ( Figure 1) . The in vitro studies support their actions on endothelial or mesangial cell programs. Mutations for mouse Fibulins 1, 3, 4, and 5 have strong pleiotropic phenotypes including hemorrhages in multiple tissues and defects in the capillaries heart, lung, and kidney including impaired formation of glomerular capillaries and abnormal cell junctions in Fbln1 mutants (Kostka et al., 2001) . However, in mouse, Fbln2 mutants are viable with no reported kidney phenotype and Fbln2 is localized quite differently in the mouse kidney (Olijnyk et al., 2014) when compared with its human ortholog. We hypothesize that developmentally restricted expression of FBLN2 may perform highly specialized functions directing glomerular vascularization in human kidney development replacing some of the functions of Fbln1 in mouse. Thus far, human FBLN2 has not been linked to human disease or kidney function (de Vega et al., 2009 ) but could be uncovered by genome-wide association study (GWAS)-powered investigations. However, FBLN2 has been shown to exhibit properties in non-kidney systems similar to those demonstrated here. FBLN2 regulates invasion, migration, and/or adhesion of astrocytes, keratinocytes, and cancer cells and is linked to wound healing cells (de Vega et al., 2009 , Fontanil et al., 2017 Law et al., 2012; Olijnyk et al., 2014; Schaeffer et al., 2018) . FBLN2 also shows alternate splice isoform abundance in mouse versus human (Grä ssel et al., 1999; Pfaff et al., 1995) . In contrast, disruption of Bmp4 leads to mesangial and RC defects in the mouse (Ueda et al., 2008) , suggesting that BMP4's function in human and mouse may be a conserved requirement for glomerulus development. A current goal for kidney translational research is to vascularize pluripotentderived kidney tissues in vitro and replicate glomerular function but has thus far eluded our best efforts and impedes clinical application of kidney organoids. Thus, there is an acute need for knowledge of mechanisms sufficient to direct vascularization of kidney tissue types in vitro, and our work presented here has identified three potential candidates. Future studies will focus on regulation of FBLN2, NTN4, and BMP4 to induce in vitro assembly of glomerular capillary formation, maintenance, and function. In conclusion, these studies highlight the power of single-cell analysis in the understanding of human organogenesis, predicting cell interactions and distinct pathways of action not observed in the mouse model system.
Limitations of the Study
Deidentified primary human fetal kidney tissue for nuclei profiling, imaging, and in vitro culture were received on a case-by-case basis. Limitations on the availability of tissue samples and variability in sample age and sex precluded a detailed mechanistic follow-up of the preliminary findings of BMP4-mediated regulation of mesangial GATA3 expression. Additional studies will be essential to clarify the pathway(s) of action of the signaling activities identified here and how these factors may cooperate with a broader range of signals within the developing glomerular environment. Here, GATA3 upregulation within interstitial cells could facilitate unbiased systematic screening to broadly explore pathway actions in future work.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
DATA AND CODE AVAILABILITY
snDrop-seq raw sequencing files and associated annotated count matrix are available from the Gene Expression Omnibus: GSE114569 and NCBI: 19094300. 
SUPPLEMENTAL INFORMATION
Human Kidney Material
Consented, anonymized, human fetal tissue was obtained from elective terminations through collaborators at the Children's Hospital of Los Angeles following institutional review board assessment of the study. Gestational age was determined per guidelines specified by the American College of Obstetricians and Gynecologists using ultrasound, heel-to-toe, and crown-to-rump measurements following published CSs. Stages indicate the age of the embryo or fetus from the point of conception/fertilization. Samples from the Children's Hospital of Los Angeles were received immediately after elective terminations and transported on ice at 4°C in 10% FBS, 25 mM Hepes, high-glucose DMEM (SIGMA).
Sample isolation and nuclei preparation
Human cortical nephrogenic zone cells were isolated from 13-18 week fetal human kidneys using 10 mg/ml pancreatin (Sigma, P1625) and 2.5 mg/ml collagenase A (Roche, 11 088 793 001) enzyme mixture and filtered through 40 µm filter (BD Falcon 352340) as described previously (Brown et al., 2015) . RCs were sieved from fetal kidneys by macerating on top of 100 µm filter (Falcon, 352360) with rubber plunger then flowing 5 ml of ice-cold Calcium/Magnesium free PBS through macerated tissue. The flow-through was then passed through a 70 µm filter (Falcon, 352350) to sieve RCs. The 70 µm filter was inverted over a 50 ml conical tube and 5 ml of ice-cold PBS was poured over the filter to retrieve RCs. RCs were spun down at 500 g for 10 minutes in swinging bucket rotor centrifuge. Nephrogenic cortex cells and RCs were cryopreserved with 10% FBS in DMEM or RNAlater and stored at -20 °C before subsequent nuclei extraction. Nuclei were isolated using nuclear extraction buffer (NEB) and used for snDrop-seq as described previously , with step-by-step protocols also available from https://kpmp.org/resources/.
snDrop-seq data processing and analyses
Paired-end sequencing reads were processed and mapped to the human genome (GENCODE GRCH38) as described previously (software available at https://github.com/chensong611/Dropseq_pipeline) to generate a digital expression matrix of unique molecular identifier (UMI) counts for all detected genes and for all cell barcodes. Each cell barcode was then tagged by an associated library batch ID ( Supplementary Table 1 ) and count matrices combined across independent experiments. Mitochondrial genes not expressed in nuclei and nuclei with fewer than 400 or greater than 5000 genes detected were omitted. Counts were then normalized to the total number of counts for each nucleus. For clustering, Pagoda2 (https://github.com/hms-dbmi/pagoda2) was used as described previously , with the exception that clusters having less than 50 data sets were excluded to remove outliers and possible multiplets. Two clusters (each consisting of 52 data sets each) that showed high ribosomal RNA content were also excluded. Further analyses were performed using Seurat software (V2.1.0) in R (https://github.com/satijalab/seurat) where counts for all cell barcodes used in Pagoda2 clustering were scaled by total UMI counts, multiplied by 10,000 and transformed to log space. Technical effects of batch and UMI coverage were regressed from scaled data using the RegressOut function and variable genes identified from a mean variability plot (Seurat). Cluster identities, top 150 principle components and t-SNE coordinates were imported into Seurat from Pagoda2 and differentially expressed genes (DEGs, adjusted p value < 0.05) between clusters ( Supplementary Table 4 ) were calculated using a Wilcoxon rank sum test (Seurat) on genes detected in at least 25% of cells within a cluster. UMAP dimensional reduction was performed in Seurat (version 2.3.4) using the top 150 PCs identified using Pagoda2. Gene ontology analysis on all significant DEGs for each cluster was performed using https://toppgene.cchmc.org/ ( Supplementary Table S5 ). Violin plots, dot plots, expression heatmap of top DEGs and feature plots were generated using Seurat. A pair-wise correlation plot for annotated clusters was performed using log-transformed cluster-averaged expression values for all DEGs having an adjusted p value less than 0.05 ( Supplementary Table 4 ). SWNE was performed as described (https://yanwu2014.github.io/swne/) (Wu et al., 2018) and involved nonnegative matrix factorization (NMF) to decompose the gene expression matrix into biologically relevant nonnegative factors. SWNE was then used to embed both the cells and the factors in a two-dimensional visualization, using a shared nearest neighbors (SNN) graph to ensure that cells that are close in the gene expression space are also close in the visualization. The nonnegative factors were annotated using the gene-factor loadings (analogous to using principal component loadings to interpret PCA) and projected as data points onto the visualization.
Developmental Trajectory Analyses
snDrop-seq UMI count matrices for select clusters were analyzed using Monocle software (Trapnell et al., 2014) (v2.4.0) in R according to the provided documentation (http://cole-trapnell-lab.github.io/monoclerelease/) and with UMI counts modeled as a negative binomial distribution. For all nephrogenic lineages: ordering genes were determined as the top 800 differentially expressed genes (expressed in at least 10 nuclei) that were identified using the differentialGeneTest function (Monocle) between associated clusters (Pagoda2 defined) and that were ordered by their q values. Reduction to two dimensions was performed using the discriminative dimensionality reduction with trees (DDRTree) method. To identify genes varying between proximal and medial/distal branches of the trajectory, BEAM analysis (Monocle) was performed and genes showing significant q values (<0.01) were plotted using the plot_genes_branched_heatmap function. Differentially expressed genes between data sets occupying each branch (and compared against all remaining data sets) were further identified using the Wilcoxon rank sum test (Seurat). Genes showing significant variation by pseudotime (q value < 0.01) were identified, plotted using the plot pseudotime_heatmap function (Monocle) and genes showing intermediate expression profiles were selected manually. Trajectory analyses were subsequently repeated for the proximal branch (visceral and PE, ordering on the top 500 cluster-specific DEGs) and the medial/distal branch (proximal/medial/distal tubules, ordering on the top 1200 cluster-specific DEGs) as described above. To better understand gene expression dynamics specific to the podocyte lineage, the progenitor branch (from Plot 1, Supplementary  Fig. 3a ) and the podocyte and progenitor branches (from Plot 2, Supplementary Fig. 3a) were selected for combined reanalysis. For this, cNPCs were excluded, the remaining cluster identities were merged into broad categories (NPC, dNPC, DT, MDT, PE, POD, PT), and the top 500 differentially expressed genes between the merged clusters (q values less than 0.01) were used for ordering as described above. To select for gene sets differentially expressed along this trajectory, genes showing differential expression according to pseudotime (using the differentialGeneTest function in Monocle) having q values less than 0.1 were segregated into 8 groups using hierarchical clustering (plot_pseudotime_heatmap function in Monocle). Trajectory analysis was also performed on the interstitial clusters (excluding cycling interstitial cells to prevent ordering based on cellular division) using the top 1000 cluster-specific DEGs. For differential expression between branch occupied data sets using the Wilcoxon rank sum test (Seurat), the initial branch representing a potential stressed INT-3 population was excluded. Differentially expressed genes for all trajectory analyses are provided as Supplementary Tables and are indicated in Supplementary Fig. 3 . All gene ontology analyses were performed using https://toppgene.cchmc.org/. Supplementary  Table S1 .
Statistics
Data Availability
snDrop-seq raw sequencing files and associated annotated count matrix are available from the Gene Expression Omnibus under the accession code GSE114569 and NCBI tracking system #19094300.
Human fetal kidney endothelial and interstitial cell isolation and culture
Endothelial and interstitial cells were magnetically purified from cortical nephrogenic zone cells from two independent human fetal kidney samples via autoMACS Pro Separator and anti-CD144 (VECAD) PEconjugated antibodies (Miltenyi Biotec, and CD140b (PDGFRB) PE-conjugated antibodies (Miltenyi Biotec, using positive selection. Primary HFK endothelial cells were cultured with Endothelial Cell Growth Medium (ECGM) with provided growth supplement (Promocell, C-22010), interstitial cells were cultured with MEM α, GlutaMAX™ Supplement, no nucleosides (Thermofisher, 32561037) supplemented with 10% Fetal Bovine Serum. Endothelial or interstitial cells were plated on 0.1% gelatin, cultured at 37 °C 5% CO2 in 75 cm 2 tissue culture flasks and passaged up to four times prior to in vitro experiments. All assays were performed in triplicate.
Matrigel Migration assay
Assay was performed in triplicate as described (Finkenzeller et al., 2012) with the following modifications. Growth factor reduced Matrigel (Corning, 354277) was thawed overnight at 4 C and diluted at 1:20 in ECGM without growth supplement and 100 ul was spread over a 24-well size Transwell chamber with 8 µm pore size (Falcon, 353097) and allowed to equilibrate overnight. The chamber was inserted into a 24 well culture dish containing ECGM without growth supplement and supplemented with 50 ng/ml VEGFA (R&D, 293-VE-010), 100 ng/ml VEGFA blocking antibody (R&D, MAB293-SP), 30 ng/ml FGF2 (Peprotech, 100-18B), 30 ng/ml PDGF-bb (Peprotech, 100-14B), 22.5 and 75 ng/ml FBLN2 (Mybiosource, MBS2011606), 15 and 150 ng/ml NTN4 (R&D, 1254-N4-025), 5 and 50 ng/ml BMP4 (R&D, 314-BP-010). 2.5x10 5 endothelial and/or interstitial cells were incubated in Transwell chamber for 6 hours at 37 °C in 5% CO2. Unmigrated cells were removed from upper chamber, migrated cells were fixed with 4% PFA for 10 minutes then stained with DAPI and the entire Transwell was imaged with 4x objective on ImagXpress (https://www.nikoninstruments.com/). Total migrated cell numbers were quantified in ImageJ using the Analyze Particles function (http://rsb.info.nih.gov).
Matrigel endothelial tube formation assay
Assay was performed as described (Finkenzeller et al., 2012) with the following modifications. Matrigel was spread evenly over each well of a 96-well plate and allowed to solidify for 30 minutes at 37 °C. 1x10 5 primary endothelial cells were seeded in triplicate into each well with ECGM without supplement and with factors indicated. Plates were incubated for 24 hours at 37 °C in 5% CO2 then imaged by ImagXpress High-Content Analysis system with 20x objective and analyzed using ImageJ. For quantification the entire field was imaged and total length of endothelial tubes and number of branch points was manually quantified (n=3). Results were expressed as means ± standard deviation with significance calculated for differences between control and experimental groups.
BrdU inclusion assay
1x10 5 primary endothelial or interstitial cells were plated in triplicate into 0.1% gelatin-coated 96 well plates with basal media supplemented with 2% Fetal Bovine Serum and factors indicated. Cells were cultured for 24 hours at 37 °C in 5% CO2 then stained for Brdu according to manufacturers' instructions for 2 hours (Thermofisher, B23151). Cells were fixed, stained with anti-BrdU (BD, 555627, 1:1000), anti-PECAM1, and/or anti-PDGFRB, and DAPI and imaged with 10x objective on ImagXpress. Fields from each plate were analyzed using Imaris software to quantitate percent of nuclei that were BrdU positive.
Lamellar extension assay
Experiments were performed similarly to a previous study with the following modifications. Primary endothelial and/or interstitial cells were plated in triplicate into 0.1% gelatin-coated 96 well plates and allowed to grow to confluency with growth media. Prior to wound healing cells were starved of ECGM growth supplement or serum for 24 hours. Confluent cells were then scratched with a P1000 pipette tip and replaced with serum free media supplemented with indicated factors and/or inhibitors including DMPQ dihydrochloride (Sigma, SML0334-5MG), LDN-193189 (Stemgent, 04-0074-02) , U0126 (Sigma, , and/or Endorepellin (R&D, 2364-ER-050). Cells were allowed to migrate for 0 or 7 hours then fixed and stained with Phalloidin 647 (Thermofisher, A22287, 1:1000) and DAPI and imaged with 10x objective on Leica SP8. Quantitation of wound healing was performed by measuring Actin-and DAPI-area in wounds in ImageJ, calculating the area differential, then dividing by the length of the wound to calculate average lamellar cell extension length.
Cell Adhesion assay
Individual wells of Immulon 4 HBX 96 well plates (Thermofisher, 3855) were coated with 10 ug/ml BMP4, NTN4, FBLN2, or BSA in 10 mM Acetic Acid at 4 C overnight. Protein was aspirated then nonspecific binding of cells to plate were blocked with 5% BSA for 1 hour. Wells were washed three times with PBS. 3x10 5 primary endothelial or interstitial cells were plated in triplicate onto coated plates in serum free MEM α. Cells allowed to attach at room temperature for 1 hour then non-adherent cells were washed off three times with PBS and counted manually. Cells were fixed, stained with anti-FBLN2 and anti-HSPG2/Perlecan antibodies and DAPI and imaged with 25x objective on Leica SP8.
BMP4 induction assay
Primary interstitial cells were cultured in MEM α with 2% serum supplemented with factors indicated in triplicate and grown for 0, 12, 24, and 48 hrs at 37 °C in 5% CO2. Cells were fixed at specified timepoints, stained for GATA3, PDGFRB, and DAPI and imaged with 25x objective on Leica SP8. Quantification of average protein intensity per cell was performed in Imaris on three fields. Cells were collected for RNA at specified timepoints, cDNA synthesized with Superscript IV VILO, and QCPR was performed on Viia 7 (Applied Biosystems) for GAPDH (Fwd-GGAGCGAGATCCCTCCAAAAT, Rev-GGCTGTTGTCATACTTCTCATGG), ID1 (Fwd-CTGCTCTACGACATGAACGG, Rev-GAAGGTCCCTGATGTAGTCGAT) and GATA3 (Fwd-GCCCCTCATTAAGCCCAA, Rev-TTGTGGTGGTCTGACAGTTCG). Delta Ct method was used to calculate fold change relative to 0 hr sample. (Table S4) . Fig. S3, related to Fig. 2. Developmental trajectory analyses. (a) UMAP plot as shown in Fig.  1a highlighting major cell populations (nephrogenic mesenchyme -red, interstitium, blue) used for pseudotemporal ordering using Monocle. Panels (1) to (5) represent five separate trajectories: (1) global nephrogenic mesenchyme trajectory; (2) proximal nephrogenic mesenchyme trajectory to generate parietal and visceral epithelial cell types of the RC; (3) medial/distal mesenchyme trajectory to give rise to the proximal, medial and distal tubules of the nephron; (4) interstitial lineage trajectory towards distinct INT-1/2 and INT-3 lineages; (5) progenitor trajectory to give rise to podocytes (see Methods). Supplementary tables for differentially expressed genes identified from branch-point (BEAM) analyses, global pseudotemporal analyses or that are differentially expressed between data sets occupying each branch are indicated (S6-S13, S15). Corresponding marker genes are indicated. (b) UMAP plots for all cell-type clusters (shown in top left) indicating expression level (gray = low, blue = high) of select marker genes. 
